Author:
Tian Yanlong,Gao Xiao,Yang Xuechao,Chen Shangjun,Ren Yufeng
Funder
Xianyang key research and development Project
No. 215 Hospital of Shaanxi Nuclear Industry scientific research project
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Le Rhun E, Devos P, Houillier C, Cartalat S, Chinot O, Di Stefano AL, Lepage C, Reyns N, Dubois F, Weller M. Romiplostim for temozolomide-induced thrombocytopenia in glioblastoma: the PLATUM trial. Neurology. 2019;93(19):e1799–806.
2. Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2009–2013. Neurooncology. 2016;18(suppl5):v1–75.
3. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007;25(4):867–90. vii.
4. Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol. 1997;145(7):581–93.
5. Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842–50.